INSIGHTS ON LIQUID DOSE MANUFACTURING

• The Importance Of Tube Welding In Aseptic Bioprocessing

  Sensitive biologics rely on aseptic processing and single‑use systems, making dependable sterile connections essential. See how tube welding offers a reliable way to reduce contamination.

• BioTitan Retention Device Overview

  Learn about a retention device that provides robust fortification for single-use assemblies. Its 360-degree seal strengthens connections, reduces leak risks, and ensures process integrity for fluid transfer.

• Cutting Through Complexity: An Integrated Model For Faster PFS Development

  Discover how integrated, end-to-end development for prefilled syringes can streamline timelines, enhance patient-centric delivery, and scale efficiently from early development to global launch.

• Support Of Scale-Up And Technical Transfer Through Understanding Equipment

  See how our expertise in formulation and process development can ensure a seamless scale-up from laboratory to full-scale production of lyophilized injectable products.

• Afton Scientific Capabilities Update January 2026: Fill/Finish

  1/27/2026

  Here, Michael Dunn outlines our current available capacity, including RABS operations, alongside the commissioning of a new Annex 1–compliant isolator filling line and expanded QC capabilities to ensure reliable, scalable execution.

• Upperton Capabilities Update April 2026: Fill/Finish

  4/28/2026

  An inside look at a modern Annex 1–compliant sterile facility designed for flexible aseptic and terminally sterilised manufacturing across multiple drug delivery routes.

• Finding The Right Aseptic Processing Approach

  8/28/2024

  How should you approach building your aseptic processing line? Gain insight into the advantages of using a modular, configurable technology rather than custom fill-finish solutions.

• Solutions In Pre-Filled Syringes For Biologics And Ophthalmic Applications

  6/19/2025

  Discover how pharma companies can select tailored pre-filled syringes for biologics and biosimilars by aligning drug delivery needs with specialized containers and analytical services.

• Minimizing Particulate Risk

  5/13/2026

  While visible particles often draw immediate attention, visual inspection alone is insufficient, as subvisible particulate matter can pose equally significant risks to patient safety.